Related Experiment Video
Updated: Jun 5, 2026

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
The complement system in inflammatory bowel disease: from early observations to emerging frontiers
Bryan Ramirez Reyes1, Devesha Kulkarni
1Department of Medicine, David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California, USA.
The complement system plays a dual role in inflammatory bowel disease (IBD), with its overactivation worsening inflammation and impaired function compromising host defense. Understanding these context-dependent effects is crucial for developing new IBD therapies.
Area of Science:
- Innate immunity
- Complement system biology
- Gastrointestinal immunology
Background:
- The complement system, an evolutionarily conserved innate immunity component, is increasingly recognized for its role in intestinal inflammation.
- Historical observations of complement deposition and elevated levels in IBD patients have evolved into a complex understanding of its functions.
- Recent research highlights the dichotomous role of complement in IBD, acting as both protective and pathogenic.
Purpose of the Study:
- To review recent advances in complement biology relevant to IBD.
- To examine how complement influences intestinal immune responses during inflammation.
- To discuss the therapeutic implications of complement's role in IBD.
Main Methods:
- Review of recent scientific literature on complement system and IBD.
- Analysis of findings from genome-wide association studies.
- Synthesis of current understanding of complement's protective and pathogenic roles.
Main Results:
- The complement system comprises over 60 proteins involved in host defense.
- Local synthesis and activation of complement components occur at mucosal sites, including the colon.
- Genetic variants in complement genes are associated with severe IBD complications.
- Complement exhibits a dual role in IBD: excessive activation exacerbates inflammation, while impaired function worsens disease outcomes.
Conclusions:
- Complement-targeted therapies have shown success in other diseases but not yet in IBD.
- Further research into the context-dependent protective and pathogenic functions of complement is necessary.
- Developing effective future therapeutic strategies for IBD requires a deeper understanding of complement's intricate roles.
Related Concept Videos
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Complement System
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

